Pentoxifylline for intermittent claudication [PDF]
Cochrane Database of Systematic Reviews, 2015 Intermittent claudication (IC) is a symptom of peripheral arterial disease (PAD) and is associated with high morbidity and mortality. Pentoxifylline, one of many drugs used to treat IC, acts by decreasing blood viscosity, improving erythrocyte flexibility and promoting microcirculatory flow and tissue oxygen concentration.
Abdel-Hadi, M. +5 more
core +8 more sources
Buflomedil for intermittent claudication [PDF]
Cochrane Database of Systematic Reviews, 2013 Background : Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest. Buflomedil is a vasoactive agent used to treat peripheral vascular disease.
De Backer, Tine, Vander Stichele, Robert
core +10 more sources
Exercise for intermittent claudication [PDF]
Cochrane Database of Systematic Reviews, 2014 Exercise programmes are a relatively inexpensive, low-risk option compared with other more invasive therapies for leg pain on walking (intermittent claudication (IC)). This is an update of a review first published in 1998.The prime objective of this review was to determine whether an exercise programme in people with intermittent claudication was ...
Lane, Risha +3 more
+11 more sources
Cilostazol for intermittent claudication. [PDF]
Cochrane Database Syst Rev, 2021 Peripheral arterial disease (PAD) affects between 4% and 12% of people aged 55 to 70 years, and 20% of people over 70 years. A common complaint is intermittent claudication (exercise-induced lower limb pain relieved by rest). These patients have a three- to six-fold increase in cardiovascular mortality.
Brown T +5 more
europepmc +10 more sources
Stages of health behavior change and factors associated with physical activity in patients with intermittent claudication [PDF]
Einstein (São Paulo), 2012 OBJECTIVE: To analyze, in people with intermittent claudication, the frequency of individuals who are in each of stages of health behavior change to practice physical activity, and analyze the association of these stages with the walking capacity ...
Barbosa, João Paulo dos Anjos Souza +7 more
core +4 more sources
Barriers and enablers to walking in individuals with intermittent claudication: a systematic review to conceptualize a relevant and patient-centered program [PDF]
PLoS ONE, 2018 Background: Walking limitation in patients with peripheral arterial disease (PAD) and intermittent claudication (IC) contributes to poorer disease outcomes.
Abaraogu, Ukachukwu +7 more
core +6 more sources
Remote ischemic preconditioning in patients with intermittent claudication [PDF]
Clinics, 2013 OBJECTIVE: Remote ischemic preconditioning (RIPC) is a phenomenon in which a short period of sub-lethal ischemia in one organ protects against subsequent bouts of ischemia in another organ.
Chehuen, M +9 more
core +6 more sources
A Systematic Review of the Uptake and Adherence Rates to Supervised Exercise Programs in Patients with Intermittent Claudication [PDF]
Annals of Vascular Surgery, 2016 Background Intermittent claudication (IC) is a common and debilitating symptom of peripheral arterial disease and is associated with a significant reduction in a sufferer's quality of life.
Broadbent, Edward +4 more
core +2 more sources
Quality of life in patients with intermittent claudication [PDF]
Gefässchirurgie, 2017 © 2017, The Author(s). Background: Intermittent claudication (IC) is a common condition that causes pain in the lower limbs when walking and has been shown to severely impact the quality of life (QoL) of patients.
Broadbent, E. +4 more
core +2 more sources
Predictors of walking capacity in peripheral arterial disease patients [PDF]
Clinics, 2013 OBJECTIVE: To estimate walking capacity in intermittent claudication patients through a prediction model based on clinical characteristics and the walking impairment questionnaire. METHODS: The sample included 133 intermittent claudication patients of
Chehuen, MR +7 more
core +4 more sources